|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/10 | (2006.01) |
| A61K 9/50 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61J 3/00 | (2006.01) |
| (11) | Number of the document | 2328601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09789142.8 |
| Date of filing the European patent application | 2009-08-14 | |
| (97) | Date of publication of the European application | 2011-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-22 |
| (46) | Date of publication of the claims translation | 2020-04-27 |
| (86) | Number | PCT/US2009/004675 |
| Date | 2009-08-14 |
| (87) | Number | WO 2010/019266 |
| Date | 2010-02-18 |
| (30) | Number | Date | Country code |
| 89422 P | 2008-08-15 | US | |
| 273332 P | 2009-08-03 | US | |
| 231725 P | 2009-08-06 | US |
| (72) |
FRETZEN, Angelika, US
WITOWSKI, Steven, US
GROSSI, Alfredo, US
ZHAO, Hong, US
DEDHIYA, Mahendra, US
MO, Yun, US
|
| (73) |
Ironwood Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, Massachusetts A 02142,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Linaklotidą turinčios vaisto formos, skirtos vartoti per burną |
| LINACLOTIDE-CONTAINING FORMULATIONS FOR ORAL ADMINISTRATION |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 17 | 347.00 EUR |
| 2026-08-14 |